Genomma Lab Internacional SAB de CV
BMV:LABB
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
12.54
27.49
|
Price Target |
|
We'll email you a reminder when the closing price reaches MXN.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one LABB stock under the Base Case scenario is 26.75 MXN. Compared to the current market price of 26.3 MXN, Genomma Lab Internacional SAB de CV is Undervalued by 2%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Genomma Lab Internacional SAB de CV
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for LABB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Genomma Lab Internacional SAB de CV
Balance Sheet Decomposition
Genomma Lab Internacional SAB de CV
Current Assets | 12B |
Cash & Short-Term Investments | 1.2B |
Receivables | 7.2B |
Other Current Assets | 3.6B |
Non-Current Assets | 10B |
PP&E | 3.5B |
Intangibles | 5.5B |
Other Non-Current Assets | 921.2m |
Current Liabilities | 6.1B |
Accounts Payable | 1.8B |
Accrued Liabilities | 126.8m |
Other Current Liabilities | 4.2B |
Non-Current Liabilities | 5.3B |
Long-Term Debt | 4.9B |
Other Non-Current Liabilities | 362.5m |
Earnings Waterfall
Genomma Lab Internacional SAB de CV
Revenue
|
16.8B
MXN
|
Cost of Revenue
|
-6.2B
MXN
|
Gross Profit
|
10.6B
MXN
|
Operating Expenses
|
-7.1B
MXN
|
Operating Income
|
3.4B
MXN
|
Other Expenses
|
-2.1B
MXN
|
Net Income
|
1.3B
MXN
|
Free Cash Flow Analysis
Genomma Lab Internacional SAB de CV
MXN | |
Free Cash Flow | MXN |
LABB Profitability Score
Profitability Due Diligence
Genomma Lab Internacional SAB de CV's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
Genomma Lab Internacional SAB de CV's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
LABB Solvency Score
Solvency Due Diligence
Genomma Lab Internacional SAB de CV's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Score
Genomma Lab Internacional SAB de CV's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LABB Price Targets Summary
Genomma Lab Internacional SAB de CV
According to Wall Street analysts, the average 1-year price target for LABB is 26.21 MXN with a low forecast of 15.15 MXN and a high forecast of 34.65 MXN.
Dividends
Current shareholder yield for LABB is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company is headquartered in Mexico City, Mexico, D.F.. The company went IPO on 2008-06-19. The firm is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The firm is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.
Contact
IPO
Employees
Officers
The intrinsic value of one LABB stock under the Base Case scenario is 26.75 MXN.
Compared to the current market price of 26.3 MXN, Genomma Lab Internacional SAB de CV is Undervalued by 2%.